The analgesic efficacy of erector spinae plane block for percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized controlled trials Authors: Lin Yang, Hongmei Yang, Fan Zhang, Yu Zhou, Yalan Lv, Changjian Zheng Published: 2025 ABSTRACT IntroductionThe analgesic efficacy of erector spinae plane block (ESPB) for postoperative analgesia after percutaneous nephrolithotomy(PCNL).MethodsWe searched Pubmed, Embase, Cochrane library, the Chinese Biomedical Literature Database, and randomized controlled trials (RCTs) assessing analgesic efficacy of ESPB for PCNL are included in this meta-analysis.The related trials met the inclusion criteria were analyzed using RevMan 5.4 and GRADE pro software.ResultsNine RCTs are included in the meta-analysis showed that ESPB group had significantly lower requirement of opioid consumption (MD-20.66 ,95% CI -34.84 to-6.49;P<0.00001),lower pain scores with ESPB use throughout the 24-hour postop period(MD -0.56,95% CI -0.90 to -0.22;P=0.001) and longer the first rescue time in minutes(MD52.68, 95% CI 8.66 to 96.7,P=0.02) ,in hours (MD11.76, 95% CI 5.59 to 17.92, P=0.0002),respectively.ConclusionThe available evidence suggests that ESPB was an efficient and safe procedure for postoperative pain management in PCNL. Introduction Kidney stone is one of the most common diseases in urology. Because percutaneous nephrolithotomy has less invasion and morbidity than open surgery, it is regarded as the gold standard for treating renal stones larger than 2 cm in diameter or complex kidney stones [1]. To the best of our knowledge, routine PCNL frequently induces urine drainage and stops percutaneous tract bleeding by indwelling a nephrostomy tube following surgery. In addition to standard PCNL, Miniperc and Multiperc are also widely used in the treatment of urinary calculi. However, this study focuses on PCNL because it remains the main method for dealing with larger (>2cm) or complex kidney stones and is also a typical scenario for the application of ESP nerve block [2].However, when a nephrostomy tube is put during PCNL, postoperative discomfort may arise. Opioids by themselves can produce respiratory depression, and pain associated with PCNL may induce nausea and vomiting. Thus, we have concentrated on reducing postoperative pain and suffering because managing postoperative pain is a crucial aspect of postoperative treatment. PCNL with no tubes, or even without any tubes at all, has shown less pain following surgery [3].However, the rementioned methods weren't frequently employed in clinical settings, which could cause infectious or bleeding complications post operation. Although the severity of postoperative pain after PCNL has decreased due to the miniaturization of the equipment, pain remains an important factor affecting the postoperative recovery of patients. Optimizing the postoperative analgesia program can not only relieve pain, but also reduce the length of hospital stay and postoperative complications. Another option to postoperative pain management after PCNL is regional anesthetic techniques. Ultrasound guided erector spinae plane block(ESPB) is a regional nerve block technique in which local anesthetic is reported to be administered into the interfascial plane between the transverse process of the vertebra and the erector spinae muscles, spreading to multiple paravertebral spaces. ESP nerve block is performed during the operation under ultrasound guidance. The needle tip is located on the surface of the transverse process of the vertebral body, and local anesthetic drugs are injected to open the myofascial space. Among the included studies, the implementation level range of ESP was from T7 to T11.Forero [4] was first described the ESPB and recently we found that ESPB is to be useful after PCNL pain management. The earliest application of ESPB technology in PCNL postoperative pain control was published in 2019.Some of related randomized controlled trials were published in the following four years. Especially the high-quality research [5–7] in recent years showed that ESPB have provide pain relief in patients who underwent percutaneous nephrolithotomy. This systematic review and meta-analysis of randomized controlled trials (RCTs) aims to assess the analgesic efficacy of ESPB for PCNL. Material and method Our study was performed by following the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement [8].The protocol (CRD340260) of this systematic review was published in the PROSPERO register (www.crd.york.ac.uk/PROSPERO). Search strategy Pubmed, Embase, the Cochrane Library, and the Chinese Biomedical Literature Database were of the databases we searched through. June 2023 was the updated end date for the retrieval time. In addition, we performed a manual search of the references for pertinent research in the grey literature and peer-reviewed abstracts that had been included in meeting proceedings. The following keywords were searched for in the above said databases-(((Percutaneous nephrolithotomy) OR (PCNL))AND ((erector spinae plane block) OR (ESPB)) OR (ESP block)). Eligibility criteria The inclusion criteria were defined by the population, intervention, comparison, outcome, and study design (PICOS) principle. The inclusion criteria included (1) RCTs; (2) studies that included adult participants under going standard PCNL, with the exception of tubeless PCNL; (3) studies that compared the effect of ESPB with that of no block; and (4) studies that reported outcomes associated with at least any of the outcomes listed below: postoperative opioids needed; pain intensity verbal rating scale (VAS);and incidence of postoperative nausea vomiting (PONV). The exclusion criteria included (1) non-randomized studies; (2) patients had to be less than 18 years;(3) studies that compared the effect of ESPB with other regional analgesic techniques(local infection or coagulation disorders); and (4) studies without inadequate information for extraction. Data extraction, quality of studies and risk of bias assessment All data extracted from the included studies were recorded in an electronic database by two investigators (Zheng CJ and Yu Zhou),and any discrepancy was resolved in consultation with Yalan Lv. Collected data included main author, year of publication; country of origin; design of the study; number and age of participants; BMI and outcomes measured. All full-text articles were categorized according to Cochrane Collaboration Reviewers' Handbook. The risk of bias was independently assessed by two paired investigators (Zheng CJ and Yu Zhou) for all full-text included studies using Cochrane tools.. Seven items were evaluated in this method. These items were categorized as having a "low risk of bias," "high risk of bias," or "unclear risk of bias". Data analysis RevMan 5.4 and GRADE pro were the two software programs used for all of the meta-analyses. Statistical analysis methods and effect sizes were selected based on the objective of the evaluation and the sort of data analyzed. In this meta-analysis, the risk ratio (RR) with 95% CI for the dichotomous results and the mean difference (MD) with their corresponding 95% CI were calculated for continuous variables. For homogeneous data, fixed effect models were estimated; for heterogeneous data, random effects analysis was performed out. Heterogeneity among the studies was evaluated using X 2 statistics (P = 0.10). Forest plots were utilized to express the meta-analysis results. Sensitivity analysis was also carried out to identify the impact on the entire effect. Results Study selection and characteristics In total, 53 relevant pieces of literature were searched, as well as one from the references of the retrieved papers. After an initial screening of title and abstract, 37 irrelevant studies were excluded. Then 17 studies came to full-text assessment(The reasons for exclusion: four different interventions, e.g. PVB.QLB vs ESPB, two disagree with the inclusion criteria, one n-RCT and one no enough data) and finally, there were nine studies [6–14] that included 630 patients were determined as appropriated to include into our meta-analysis. The literature screening flowchart is shown in Figure 1. All of the nine were RCTs and they were published from 2019 to 2022. Of the nine articles, three from India, China and Turkey each have two articles, one from Poland and one from Egypt. The baseline characteristics of the nine RCTs are summarized in Table 1.Table 1Basic characteristics of included studiesAuthor/YearStudy designCountryESPB group/Control groupESPB TechniqueBMIPCNL Technique MeasuredOutcomesNumberAge,yearsSarkar S [5] 2022RCTIndia17/1642.1± 13.7/43.4 ±10.720 mL of 0.25% bupivacaineNRStandard PCNL and mini-PCNL Opioid usage,VAS,the first rescue time,operation timeSeyma [6] 2022RCTTurkey29/2853.0 ± 10.4/52.0 ± 10.515 mL of0.5% bupivacaine27.4 ± 4.2/27.1 ± 3.8 Standard PCNL Opioid usage,VAS,operation timeBryniarski P [9] 2021RCTPoland34/3455.2 ±10/57.4± 11.320 mL of 0.5% bupivacaine28.5 ±3.6/28.7 ± 3.7 Standard PCNL Opioid usage,PONV,VAS,operation timeGultekin MH [10] 2020RCTTurkey30/3055.1±15.7/52.6±10.8 20 ml of 0.5% bupivacaine24.5±5.8/25.6 ±6.4Standard PCNL Opioid usage,VAS,the first rescue timePrasad MK[11]2020RCTIndia31/3041.03±12.58/37.37±16.81 20 ml of 0.375% ropivacaine22.41±1.54/22.43±1.76Standard PCNL Opioid usage,PONV,VAS,the first rescue time,operation timeIbrahim M [12] 2019RCTEgypt25/2518–6530mLof 0.25% bupivacaine 26.6±NR/27.9±NRStandard PCNL Opioid usage,PONV,the first rescue time,operation timeWangYN [13] 2020RCTChina34/3347.4±11.8/47.2±13.030 mL of 0.5% ropivacaineNRStandard PCNL PONV,VAS,operation timeChen Y [7]2022RCTChina51/51 hh58.2±77.16/58.62±7.3830 ml of 0.25% ropivacaine35.04±1.32/35.12±1.59 NROpioid usage,VAS,operation timeSrinivasan R [14] 2021RCTIndia33/33 46.64±13.5/44.15±14.520 mL of 0.25% bupivacaine23.83±3.94/24.38±3.43Standard PCNL Opioid usage,VAS,PONV,operation timeBMI Body mass index, NR Not reported, PCNL Percutaneous nephrolithotomyFig. 1PRISMA flow diagram of the systematic literature search Table 1Basic characteristics of included studiesAuthor/YearStudy designCountryESPB group/Control groupESPB TechniqueBMIPCNL Technique MeasuredOutcomesNumberAge,yearsSarkar S [5] 2022RCTIndia17/1642.1± 13.7/43.4 ±10.720 mL of 0.25% bupivacaineNRStandard PCNL and mini-PCNL Opioid usage,VAS,the first rescue time,operation timeSeyma [6] 2022RCTTurkey29/2853.0 ± 10.4/52.0 ± 10.515 mL of0.5% bupivacaine27.4 ± 4.2/27.1 ± 3.8 Standard PCNL Opioid usage,VAS,operation timeBryniarski P [9] 2021RCTPoland34/3455.2 ±10/57.4± 11.320 mL of 0.5% bupivacaine28.5 ±3.6/28.7 ± 3.7 Standard PCNL Opioid usage,PONV,VAS,operation timeGultekin MH [10] 2020RCTTurkey30/3055.1±15.7/52.6±10.8 20 ml of 0.5% bupivacaine24.5±5.8/25.6 ±6.4Standard PCNL Opioid usage,VAS,the first rescue timePrasad MK[11]2020RCTIndia31/3041.03±12.58/37.37±16.81 20 ml of 0.375% ropivacaine22.41±1.54/22.43±1.76Standard PCNL Opioid usage,PONV,VAS,the first rescue time,operation timeIbrahim M [12] 2019RCTEgypt25/2518–6530mLof 0.25% bupivacaine 26.6±NR/27.9±NRStandard PCNL Opioid usage,PONV,the first rescue time,operation timeWangYN [13] 2020RCTChina34/3347.4±11.8/47.2±13.030 mL of 0.5% ropivacaineNRStandard PCNL PONV,VAS,operation timeChen Y [7]2022RCTChina51/51 hh58.2±77.16/58.62±7.3830 ml of 0.25% ropivacaine35.04±1.32/35.12±1.59 NROpioid usage,VAS,operation timeSrinivasan R [14] 2021RCTIndia33/33 46.64±13.5/44.15±14.520 mL of 0.25% bupivacaine23.83±3.94/24.38±3.43Standard PCNL Opioid usage,VAS,PONV,operation timeBMI Body mass index, NR Not reported, PCNL Percutaneous nephrolithotomy Basic characteristics of included studies BMI Body mass index, NR Not reported, PCNL Percutaneous nephrolithotomy PRISMA flow diagram of the systematic literature search Risk of bias assessment The results of bias risk assessment for all RCTs are shown in Figure 2. All the included studies were rated as medium- or high-quality, and no low-quality literature was included.All included studies were reported randomization.Allocation concealment was adequately conducted in 8 studies. Blinding was described in 6 studies.There were no other biases found in included studies.Fig. 2Risk of bias graph of the included RCTs Risk of bias graph of the included RCTs Meta-analysis Opioid consumption There were five studies[6.8–10.13.8.13] that reported opioid consumption at 24 hours after surgery. Above of them, three studies [6.9–10.9] reported the tramadol consumption, one reported [9] nalbuphine consumption and one reported [7] the sufentanil consumption. The pooled result of meta-analysis indicated that there was statistically significant difference between the the experimental group and the control group, with the pooled MD values of −20.66 (95% CI −34.84 to −6.49; P<0.00001,Figure 3).Sensitivity analysis: only including tramadol consumption studies analyzed, the total amount of tramadol used was lower in ESPB group(MD −64.32,95% CI −85.85 to −42.8; P<0.00001).The GRADE the strength of recommendation for opioids consumption is moderate (table 2).Table 2GRADE the strength of recommendation for each outcomeQuality evaluationThe results summaryStudy quantity and designrisk of biasInconsistencyIndirectnessimprcisionPublication biasNo.of patientsRR(95%CIAbsolute riskQualiyESPB groupControl groupControl group riskPoor riskOpioid consumption(5 RCTs)seriousseriousnot seriousseriousnone161163−20.66 (−34.84~ −6.49)-Significant statistically⨁⨁⨁◯ModeratePain intensity (VAS 6 h,2 RCTs)seriousseriousnot seriousnot seriousmay exist5958−1.97(−2.72~ −1.22)-Significant statistically⨁⨁◯◯lowPain intensity (VAS 24 h,5 RCTs)seriousseriousnot seriousseriousnone177176−0.56(−0.9~ −0.22)-Significant statistically⨁⨁⨁◯ModeratePONV(4 RCTs)seriousseriousseriousseriousnone12/13121/1300.58(0.3~1.11)162/1000No statistically⨁⨁⨁◯ModerateOperation time (6 RCTs)not seriousnot seriousnot seriousnot seriousnone1771741.36(−2.44~5.15)-No statistically⨁⨁⨁⨁HighFirst rescue time (min,2 RCTs)seriousseriousnot seriousseriousmay exist555552.68(8.66 ~96.7)-Significant statistically⨁⨁⨁◯ModerateFirst rescue time (hour,2 RCTs)seriousseriousnot seriousseriousmay exist484611.76(5.59~ 17.92)-Significant statistically⨁⨁⨁◯ModerateFig. 3Forest plot and funnel plot of opioid consumption Table 2GRADE the strength of recommendation for each outcomeQuality evaluationThe results summaryStudy quantity and designrisk of biasInconsistencyIndirectnessimprcisionPublication biasNo.of patientsRR(95%CIAbsolute riskQualiyESPB groupControl groupControl group riskPoor riskOpioid consumption(5 RCTs)seriousseriousnot seriousseriousnone161163−20.66 (−34.84~ −6.49)-Significant statistically⨁⨁⨁◯ModeratePain intensity (VAS 6 h,2 RCTs)seriousseriousnot seriousnot seriousmay exist5958−1.97(−2.72~ −1.22)-Significant statistically⨁⨁◯◯lowPain intensity (VAS 24 h,5 RCTs)seriousseriousnot seriousseriousnone177176−0.56(−0.9~ −0.22)-Significant statistically⨁⨁⨁◯ModeratePONV(4 RCTs)seriousseriousseriousseriousnone12/13121/1300.58(0.3~1.11)162/1000No statistically⨁⨁⨁◯ModerateOperation time (6 RCTs)not seriousnot seriousnot seriousnot seriousnone1771741.36(−2.44~5.15)-No statistically⨁⨁⨁⨁HighFirst rescue time (min,2 RCTs)seriousseriousnot seriousseriousmay exist555552.68(8.66 ~96.7)-Significant statistically⨁⨁⨁◯ModerateFirst rescue time (hour,2 RCTs)seriousseriousnot seriousseriousmay exist484611.76(5.59~ 17.92)-Significant statistically⨁⨁⨁◯Moderate GRADE the strength of recommendation for each outcome Forest plot and funnel plot of opioid consumption Pain intensity Five studies [7–9.13.13–14]evaluated the VAS score at the postoperative 6 h or 24 h period. Pooling the data from these studies referred to VAS scores after 6 h (MD −1.97,95% CI −2.72 to −1.22; P<0.00001)and 24h(MD −0.56,95% CI −0.90 to −0.22; P=0.001) after operation showed were significantly lower in the patients in the experimental group than in patients in the control group (Figure 4).The GRADE the strength of recommendation for VAS is low to moderate (table 2).Fig. 4Forest plot and funnel plot of VAS Forest plot and funnel plot of VAS Postoperative nausea and vomiting Four studies[8.10.13−14] provided available data on the assessment of postoperative nausea and vomiting in two groups and one of them [13] separately report the incidence of postoperative nausea or vomiting. In the remaining four studies, we used RR for statistical analysis. The data was heterogeneous (I2 = 48%), so we used fixed effects model. The meta-analysis showed that there was no statistically significant difference between the two group (RR 0.58;95%CI 0.30 to1.11,P = 0.10,Fig. 5). The GRADE the strength of recommendation for PONV is moderate (Table 2).Fig. 5Forest plot and funnel plot of nausea and vomiting Forest plot and funnel plot of nausea and vomiting Operation time Pooling the data from the 6 studies [6–8.10.10–14] showed there was no statistically significant difference in operation time between the experimental group and the control group (MD1.36, 95% CI −2.44 to 5.15, P = 0.48; Fig. 6). The GRADE the strength of recommendation for operation time is high (Table 2).Fig. 6Forest plot and funnel plot of operation time Forest plot and funnel plot of operation time The first rescue time Four studies[6.9–11] provided available data on the assessment of the first rescue analgesia time in two groups. The time to first rescue analgesia was significantly longer in ESPB group in minutes(MD52.68, 95% CI 8.66 to 96.7, P = 0.02), in hours (MD11.76, 95% CI 5.59 to 17.92, P = 0.0002),respectively (Fig. 7). The GRADE the strength of recommendation for first rescue time is moderate (Table 2).Fig. 7Forest plot and funnel plot of the first rescue time Forest plot and funnel plot of the first rescue time Discussion Urinary calculi is one of the most common diseases in urology practice and percutaneous nephrolithotomy is a common method for treatment of upper urinary calculi, especially kidney stones(> 2 cm).In the case of PCNL, there has been a trend towards miniaturization of the instruments used, to evade complications and pain associated with the procedure. The usual tract size terminology considers 24-30Fr access tract as standard PCNL (s-PCNL), 14-22Fr as mini PCNL (m-PCNL) and 11-13Fr as ultra-mini PCNL(um-PCNL).Pain after PCNL is caused by the dilatation of the renal capsule and parenchymal tract, as it is rich in pain-sensing nerves, and leads to increased hospitalization times. in an effort to lessen postoperative pain issues, researchers are continuously researching.an essential component of effective postoperative pain treatment is regional analgesia.according to certain research [15–18], there may be some benefits to local anesthetic infiltration surrounding the nephrostomy tract in terms of the necessity for analgesia.the impact of local anesthetic infiltration around the nephrostomy tract on postoperative pain, however, has to be further investigated.subsequently, paravertebral blocks are as a means of treating pain.according to research by ak [19] and anuradha [20], paravertebral block improved patient satisfaction and offered effective postoperative analgesia for patients undergoing percutaneous nephrolithotomy.at present, we pay more attention to espb since a block described by ferora in 2016 [4].the basic esp block technique involves ultrasound-guided the need to identified the erector spinal muscle and the needle is advanced to the transverse process through the erector spinal muscle.after contact with the transverse process, the erector spinal muscle is hydro-dissected off the transverse process to open the plane of the erector spinae fascia.the relatively large volume of local anesthetic into this plane can provide an analgesic effect on several dermatomes.the current evidence showed that direct spread and action of local anesthetic on neural targets is the most plausible fundamental mechanism of analgesia provided by the esp block.a systemic effect of elevated local anesthetic plasma concentrations is less likely to be a significant contributor, especially for single-injection blocks.it was found to be effective in postoperative analgesia for thoracotomy, abdominal surgery, breast surgery, and hip surgery [21].pehlıvan [22] retrospective analyzed that ultrasound-guided espb reduced postoperative morphine consumption and the rate of nausea and vomiting.prashant [23]and srinivasan [24]studies showed that espb compared to conventional peritubal local anesthetic infiltration had more advantageous to relieve pain after pcnl.meanwhile, the optimal timing of esp implementation (before or after general anesthesia) may have an impact on its therapeutic effect.among the included studies, esp was implemented in 4 studies before general anesthesia induction, and another 5 studies were implemented after general anesthesia induction.the implementation timing of esp may have an impact on its therapeutic effect. existing literature indicates that implementing esp before general anesthesia induction may improve intraoperative and postoperative analgesic effects through more effective drug diffusion. however, the subgroup analysis of this study did not find any difference in therapeutic effect before and after general anesthesia, possibly due to the large heterogeneity. we suggest that the implementation timing of esp be selected based on the convenience of actual operation and the patient’s condition.more importantly, contraindications should be excluded.the contraindications for esp include but are not limited to: local infection, coagulation disorders, local anesthetic drug allergy, and spinal anatomical abnormalities (such as severe scoliosis or deformity). these contraindications mainly stem from the possible increased risks of infection, bleeding or drug toxicity. patients with coagulation dysfunction were excluded from all the included studies. This review report on outcomes of various ESPB for management of pain following PCNL.In our study, there were 2 types of drugs used for ESPB in the included studies, ropivacaine (3 studies, three different doses,0.25%,0.375% and 0.5%) and bupivacaine (6 studies, two different doses,0.25% and 0.5%).All of included studies were largely consistent concerning the operational details of conducting ESPB and performed under ultrasound guidance.Four literatures reported that the ESPB was performed before induction of general anesthesia and five studies reported ESPB was performed after general anesthesia.Few studies reported that anaesthesia procedures are performed by experienced anaesthesiologists.However the diffusion effect of anestheticss may reduce the influence of puncture level.We judge whether ESPB is effective or not, opioid consumption and pain intensity are the most important reference index.In our study, tramadol and morphine are two types of drugs used after PCNL.Although the large heterogeneity in the data pooling might weaken the conclusion(Fig. 1).Subsequent sensitive analysis did not change the conclusion(MD-64.32, 95% CI −85.85 to −42.8, P < 0.00001). Additionally, nausea and vomiting were the most commonly reported side effects.but we were surprised to find that no difference was found in this study (Fig. 5).Among the 9 included studies, the local anesthetic drugs used in ESP included bupivacaine (6 studies) and ropivacaine (3 studies). The dosage of bupivacaine is concentrated at 0.25% and 0.5%, while the dosage of ropivacaine ranges from 0.25% to 0.5%. Existing evidence suggests that ropivacaine may be more suitable as the first choice drug for ESP due to its lower cardiotoxicity and longer duration of action. However, the analgesic effect of bupivacaine may be stronger in a short period of time. Therefore, the choice between the two should be based on the individualized needs of patients.According to the existing literature and the results of this study, the optimal dose of ESP drugs seems to be related to the volume and concentration of local anesthetics. It is recommended to use 20 mL to 30 mL of 0.25%−0.5% bupivacaine or ropivacaine in the management of postoperative acute pain. It should be noted that an increase in dosage may be accompanied by a higher risk of systemic toxicity, especially when the drug is administered repeatedly or when the patient’s liver and kidney functions are impaired.Our meta-analysis demonstrates that ESPB seem significantly reduce pain and the amount of opioid use and VAS score on the first postoperative day after PCNL, this meant ESPB was safe enough to patients after the PCNL procedure.With the improvement of surgical instruments, the overall trend of postoperative pain problems after PCNL has improved. However, for patients with multiple stones or complex surgical approaches, the problem of pain remains significant. The results of this study suggest the potential advantages of ESP in this type of patients. In this study, opioids were selected as the main evaluation indicators for postoperative analgesia because their dosage can directly reflect the analgesic effect of ESPB. Although NSAIDs and acetaminophen are more common in clinical practice, the effects of these drugs may not fully reflect the analgesic potential of ESP. Therefore, future studies can further compare the efficacy of ESP combined with NSAIDs or acetaminophen.The use of opioids is closely related to postoperative nausea and vomiting (PONV). In this study, the opioid usage in the ESP group was significantly lower than that in the control group (MD = −20.66, 95% CI −34.84 to −6.49, P < 0.00001), although the overall incidence of PONV did not vary significantly between the two groups (RR = 0.58, 95% CI 0.30 to 1.11). P = 0.10. Although the use of opioids may increase the risk of PONV, its actual incidence was relatively low (approximately 5–6%) in this study. However, ESP is expected to further reduce the incidence of this side effect by reducing the dosage of opioids, which is particularly important for high-risk patients.This result indicates that ESPB may reduce the risk of PONV occurrence by reducing the dosage of opioids, but more studies are still needed in the future to verify this hypothesis. Some limitations were still existing in our study.Firstly, although this study included 9 RCTs, the smallest study included only 33 participants. So small sample size might lack statistical power for results.Secondly, our meta-analysis included five countries published studies and we only considered the articles written in Chiness and English, which may contain selection bias.As only a few studies with small study populations were available, we believe that more results with high quality trials should be provided to update this study. In conclusion, our study indicated that ESPB significantly reduce VAS score and the amount of opioid use on the first postoperative day after PCNL.However, good quality and large studies with long-term follow-up are warranted for further research.